Malathi, D. C.; Janakiraman, K.; Thangavelu, S. V. A.; Ravichandran, D. Enlicitide (Lipfendra): The First Oral PCSK9 Inhibitor - from Macrocyclic Peptide Innovation to Clinical Translation. Int J Basic Clin Pharmacol 2026, 15, 1126-1134.